RhumbLine Advisers’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $639K | Buy |
|
|||||
|
2022
Q4 | $868K | Buy |
|
|||||
|
2022
Q3 | $826K | Buy |
|
|||||
|
2022
Q2 | $755K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $63K | Sell |
|
|||||
|
2018
Q4 | $49K | Buy |
|
|||||
|
2018
Q3 | $98K | Sell |
|
|||||
|
2018
Q2 | $243K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $104K | Buy |
|
|||||
|
2015
Q4 | $215K | Buy |
|
|||||
|
2015
Q3 | $213K | Buy |
|
|||||
|
2015
Q2 | $274K | Sell |
|
|||||
|
2015
Q1 | $255K | Buy |
|
|||||
|
2014
Q4 | $247K | Buy |
|
|||||
|
2014
Q3 | $246K | Hold |
|
|||||
|
2014
Q2 | $285K | Buy |
|
|||||
|
2014
Q1 | $345K | Buy |
|
|||||
|
2013
Q4 | $193K | Hold |
|
|||||
|
2013
Q3 | $165K | Buy |
|
|||||
|
2013
Q2 | $104K | Buy |
|